JGJ. N. Alastair Gibson

J. N. Alastair Gibson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


J. N. Alastair Gibson has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cervical endoscopic spinal surgery: A review of the current literature

    by Vittoria Bucknall, Jn Alastair Gibson

    Cervical endoscopic spinal surgery (CESS) is now regularly performed in some centres in the Far East, yet rarely in Europe and the United States. This review describes the application of CESS through anterior and posterior approaches with analysis of the available evidence supporting current techniques. An electronic literature search identified 52 papers and proceedings’ abstracts of which 25 (16 anterior approach and 9 posterior approach) provided comparable clinical outcomes. The results revealed a good or excellent outcome from CESS in 91% (range 74–100%) with a complication rate of 5%. In a local cohort study, patients had 72% less neck pain (visual analogue scale rating) and 81% less arm pain at 6 months when CESS was used as an isolated procedure, and 74% less neck pain and 83% less arm pain when coupled with disc replacement or fusion at an adjacent level.


  • Open Access

    Multi-level spine endoscopy: A review of available evidence and case report

    by Scott D. Middleton, Ralf Wagner, J. N. Alastair Gibson

    In the last ten years, there has been an exponential increase in endoscopic spinal surgery practice. With improvements in equipment quality and the availability of high definition camera systems, cervical endoscopic disc resection is now a viable alternative to anterior cervical decompression and fusion (ACDF) or disc arthroplasty for the treatment of disc prolapse and low grade stenosis. Based on the current literature, there is now strong evidence to support the use of transforaminal endoscopic approaches for the treatment of thoracic disc prolapse. There is now level I evidence to show that outcomes following transforaminal endoscopic discectomy (TED) are at least equivalent to those after open microdiscectomy, with an expected shorter operating time, lesser requirement for analgesia, reduced duration of post-operative disability, more rapid rehabilitation and lower costs of care. However, it should be recognised that there is a significant learning curve for TED. New endoscopic techniques with interlaminar approaches allow the decompression of central and lateral recess stenosis. Future developments will facilitate vision and access to the spine with 3D imaging and robotics at the forefront. We present a case report of whole spine endoscopic decompression to illustrate the potential of endoscopic surgery at all spinal levels. Cite this article: EFORT Open Rev 2017;2:317-323. DOI: 10.1302/2058-5241.2.160087


  • Open Access

    Cost‐effectiveness of steroid (methylprednisolone) injections versus anaesthetic alone for the treatment of Morton's neuroma: economic evaluation alongside a randomised controlled trial (MortISE trial)

    by Rhiannon Tudor Edwards, Seow Tien Yeo, Daphne Russell, Colin E Thomson, Ian Beggs, J N Alastair Gibson, Diane McMillan, Denis J Martin, Ian T Russell

    Background: Morton's neuroma is a common foot condition affecting health‐related quality of life. Though its management frequently includes steroid injections, evidence of cost‐effectiveness is sparse. So, we aimed to evaluate whether steroid injection is cost‐effective in treating Morton's neuroma compared with anaesthetic injection alone.Methods: We undertook incremental cost‐effectiveness and cost‐utility analyses from the perspective of the National Health Service, alongside a patient‐blinded pragmatic randomised trial in hospital‐based orthopaedic outpatient clinics in Edinburgh, UK. Of the original randomised sample of 131 participants with Morton's neuroma (including 67 controls), economic analysis focused on 109 (including 55 controls). Both groups received injections guided by ultrasound. We estimated the incremental cost per point improvement in the area under the curve of the Foot Health Thermometer (FHT‐AUC) until three months after injection. We also conducted cost‐utility analyses using European Quality of life‐5 Dimensions–3 Levels (EQ‐5D‐3L), enhanced by the Foot Health Thermometer (FHT), to estimate utility and thus quality‐adjusted life years (QALYs).Results: The unit cost of an ultrasound‐guided steroid injection was £149. Over the three months of follow‐up, the mean cost of National Health Service resources was £280 for intervention participants and £202 for control participants – a difference of £79 [bootstrapped 95% confidence interval (CI): £18 to £152]. The corresponding estimated incremental cost‐effectiveness ratio was £32 per point improvement in the FHT‐AUC (bootstrapped 95% CI: £7 to £100). If decision makers value improvement of one point at £100 (the upper limit of this CI), there is 97.5% probability that steroid injection is cost‐effective. As EQ‐5D‐3L seems unresponsive to changes in foot health, we based secondary cost‐utility analysis on the FHT‐enhanced EQ‐5D. This estimated the corresponding incremental cost‐effectiveness ratio as £6,400 per QALY. Over the recommended UK threshold, ranging from £20,000 to £30,000 per QALY, there is 80%‐85% probability that steroid injection is cost‐effective.Conclusions: Steroid injections are effective and cost‐effective in relieving foot pain measured by the FHT for three months. However, cost‐utility analysis was initially inconclusive because the EQ‐5D‐3L is less responsive than the FHT to changes in foot health. By using the FHT to enhance the EQ‐5D, we inferred that injections yield good value in cost per QALY.Trial registration: Current Controlled Trials ISRCTN13668166


  • Creation of an ovine model of progressive structural lordo-scoliosis using a unilateral laminar tether

    by John G. Burke, Enzo Vettorato, Gudrun Schöffmann, R. Eddie Clutton, Tim S. Drew, J. N. Alastair Gibson

    To characterise changes in vertebral dimension in an ovine model of scoliosis and determine whether a reproducible curvature could be created that would be suitable for future testing of curve modifying surgical implants. At a mean age of 5 weeks, 28 Scottish blackface sheep were anaesthetised. A 4 mm braided synthetic tape was laid under the left lamina of T5 and L1 and tightened to ‘hand’ tension. A scoliosis was then created by binding the six lowest ribs on the same side just distal to their rib angles and resecting a segment from each of the opposite ribs. Radiographs were taken at 4 weekly intervals, and CT images at 2, 5 and 7 months post tethering, to determine multi-planar curve progression. 20 animals were assessed at age 3 months, 12 at 41 weeks and 10 at 1 year with comparisons to five control animals. A significant bi-planar deformity was produced in all animals (scoliosis 32 ± 13º and lordosis 53 ± 21º 2 months post tethering; mean ± SD, n = 22). During the next 5 months the scoliosis decreased slightly (p = 0.08) but the sagittal deformity remained static: 21 ± 18° and 53 ± 19°, respectively (n = 12). The values at 7 months were associated with a mean 6 ± 4º rotational deformity. There was approximately twice as much growth in the right anterior aspects of the apical vertebrae as in the left posterior. With appropriate care it was possible to obtain a reproducible curvature in immature sheep. The methods described are suitable for use in studies of growth modulation and other spinal devices.


  • Modulation of spinal shape with growth following implantation of a novel surgical implant

    by John G. Burke, Enzo Vettorato, Gudrun Schöffmann, R. Eddie Clutton, Tim S. Drew, J. N. Alastair Gibson

    First, to determine whether scoliosis development could be limited or reversed by growth when a novel modular hinged implant was fixed to the convexity of a scoliosis created by contralateral rib and laminar tethering and unilateral rib resection in a sheep model. Second, to assess the effect and performance of the implant in normal non-tethered sheep. At 5 weeks, 20 Scottish Blackface lambs underwent surgery to create a right sided scoliosis by (i) tethering the left lamina of T5–L1 and the left lower six ribs and (ii) resecting a segment of their right lower six ribs [1, 2]. Twelve weeks later, through an antero-lateral thoracotomy, a mobile bi-planar hinged implant was inserted onto the right side of the spine of eight animals (group 1). For comparison, 12 sheep were tethered only but had no implant insertion (group 2). In addition, seven had no tethering but were implanted (group 3) and normal growth patterns were observed in five that had no surgery (group 4). Curve progression was assessed by plain radiography and CT over a 1-year period. Before implant insertion the trial animals had a scoliosis of 35º ± 16º and a lordosis of 44º ± 20º (n = 8, mean ± SD). Surgery immediately reduced these values to 25º ± 14º, p p p In the un-tethered animals the effect of the implant was to create a scoliotic deformity and in the tethered to improve deformity while maintaining spinal motion. We believe that the results are promising and that devices of similar construct may be of use in children with scoliosis, potentially changing current methods of clinical care.


  • Spine surgery—approach size does matter

    by J. N. Alastair Gibson, Susanne Merk, Menno Iprenburg


  • Surgery for disc disease

    by J N Alastair Gibson, J N Alastair

    Footnotes Competing interests: None declared. Provenance and peer review: Commissioned; not externally peer reviewed.